Literature DB >> 23245769

Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Andreas J Fallgatter1, Ann-Christine Ehlis, Thomas Dresler, Andreas Reif, Christian P Jacob, Mauricio Arcos-Burgos, Maximilian Muenke, Klaus-Peter Lesch.   

Abstract

Current research strategies have made great efforts to further elucidate the complex genetic architecture of attention-deficit hyperactivity disorder (ADHD). The present study examined the impact of an LPHN3 haplotype that has recently been associated with ADHD (Arcos-Burgos et al., 2010) on neural activity in a visual Go-NoGo task. Two hundred sixteen adult ADHD patients completed a Continuous Performance Test (CPT) while the ongoing EEG was simultaneously recorded. Results showed that patients carrying two copies of the LPHN3 risk haplotype (n=114) made more omission errors and had a more anterior Go-centroid of the P300 than patients carrying at least one LPHN3 non-risk haplotype (n=102). Accordingly, the NoGo-Anteriorization (NGA; topographical ERP difference of the Go- and NoGo-condition), a neurophysiological marker of prefrontal functioning, was reduced in the LPHN3 high risk group. However, in the NoGo-condition itself no marked differences attributable to the LPHN3 haplotype could be found. Our findings indicate that, within a sample of ADHD patients, the LPHN3 gene impacts behavioral and neurophysiological measures of cognitive response control. The results of our study further strengthen the concept of an LPHN3 risk haplotype for ADHD and support the usefulness of the endophenotype approach in psychiatric and psychological research.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245769      PMCID: PMC4131948          DOI: 10.1016/j.euroneuro.2012.11.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  72 in total

1.  Psychostimulants act within the prefrontal cortex to improve cognitive function.

Authors:  Robert C Spencer; Raymond M Klein; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2011-12-29       Impact factor: 13.382

2.  The ADHD response-inhibition deficit as measured by the stop task: replication with DSM-IV combined type, extension, and qualification.

Authors:  J T Nigg
Journal:  J Abnorm Child Psychol       Date:  1999-10

3.  COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.

Authors:  Sebastian Heinzel; Thomas Dresler; Christina G Baehne; Monika Heine; Andrea Boreatti-Hümmer; Christian P Jacob; Tobias J Renner; Andreas Reif; Klaus-Peter Lesch; Andreas J Fallgatter; Ann-Christine Ehlis
Journal:  Cereb Cortex       Date:  2012-05-22       Impact factor: 5.357

4.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

Authors:  M Arcos-Burgos; M Jain; M T Acosta; S Shively; H Stanescu; D Wallis; S Domené; J I Vélez; J D Karkera; J Balog; K Berg; R Kleta; W A Gahl; E Roessler; R Long; J Lie; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; S Johansson; P M Knappskog; J Haavik; M Ribases; B Cormand; M Bayes; M Casas; J A Ramos-Quiroga; A Hervas; B S Maher; S V Faraone; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; A Vortmeyer; J E Bailey-Wilson; F X Castellanos; M Muenke
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

5.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.

Authors:  G Bush; J A Frazier; S L Rauch; L J Seidman; P J Whalen; M A Jenike; B R Rosen; J Biederman
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

6.  Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11.

Authors:  Mauricio Arcos-Burgos; F Xavier Castellanos; David Pineda; Francisco Lopera; Juan David Palacio; Luis Guillermo Palacio; Judith L Rapoport; Kate Berg; Joan E Bailey-Wilson; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2004-10-20       Impact factor: 11.025

7.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

Authors:  S Mannuzza; R G Klein; A Bessler; P Malloy; M LaPadula
Journal:  Arch Gen Psychiatry       Date:  1993-07

9.  Executive function in adolescents with ADHD.

Authors:  Michelle Martel; Molly Nikolas; Joel T Nigg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-11       Impact factor: 8.829

10.  Oculomotor inhibition in children with and without attention-deficit hyperactivity disorder (ADHD).

Authors:  C Hanisch; R Radach; K Holtkamp; B Herpertz-Dahlmann; K Konrad
Journal:  J Neural Transm (Vienna)       Date:  2005-08-05       Impact factor: 3.850

View more
  16 in total

Review 1.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

Review 2.  Genetic Approaches to Understanding Psychiatric Disease.

Authors:  Jacob J Michaelson
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

3.  ADGRL1 haploinsufficiency causes a variable spectrum of neurodevelopmental disorders in humans and alters synaptic activity and behavior in a mouse model.

Authors:  Antonio Vitobello; Benoit Mazel; Vera G Lelianova; Alice Zangrandi; Evelina Petitto; Jason Suckling; Vincenzo Salpietro; Robert Meyer; Miriam Elbracht; Ingo Kurth; Thomas Eggermann; Ouafa Benlaouer; Gurprit Lall; Alexander G Tonevitsky; Daryl A Scott; Katie M Chan; Jill A Rosenfeld; Sophie Nambot; Hana Safraou; Ange-Line Bruel; Anne-Sophie Denommé-Pichon; Frédéric Tran Mau-Them; Christophe Philippe; Yannis Duffourd; Hui Guo; Andrea K Petersen; Leslie Granger; Amy Crunk; Allan Bayat; Pasquale Striano; Federico Zara; Marcello Scala; Quentin Thomas; Andrée Delahaye; Jean-Madeleine de Sainte Agathe; Julien Buratti; Serguei V Kozlov; Laurence Faivre; Christel Thauvin-Robinet; Yuri Ushkaryov
Journal:  Am J Hum Genet       Date:  2022-07-30       Impact factor: 11.043

4.  Driver mutations in ADGRL3 are involved in the evolution of ependymoma.

Authors:  Jing Wang; Shao-Yan Xi; Qi Zhao; Yun-Fei Xia; Qun-Ying Yang; Hai-Ping Cai; Fang Wang; Yi-Ying Zhao; Huan-Jing Hu; Zhi-Hui Yu; Fu-Rong Chen; Peng-Fei Xu; Ri-Zhen Xu; Jian Wang; Ji Zhang; Chao Ke; Xiang-Heng Zhang; Fu-Hua Lin; Cheng-Cheng Guo; Yan-Chun Lv; Cong Li; Hai-Tao Xie; Qian Cui; Hong-Mei Wu; Yan-Hui Liu; Zhi Li; Hong-Kai Su; Jing Zeng; Fu Han; Zhao-Jie Li; Ke Sai; Zhong-Ping Chen
Journal:  Lab Invest       Date:  2022-01-10       Impact factor: 5.502

5.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Authors:  Ariel F Martinez; Yu Abe; Sungkook Hong; Kevin Molyneux; David Yarnell; Heiko Löhr; Wolfgang Driever; Maria T Acosta; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Biol Psychiatry       Date:  2016-07-14       Impact factor: 13.382

Review 6.  Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms.

Authors:  Eduardo F Gallo; Jonathan Posner
Journal:  Lancet Psychiatry       Date:  2016-05-13       Impact factor: 27.083

7.  Structural and Mechanistic Insights into the Latrophilin3-FLRT3 Complex that Mediates Glutamatergic Synapse Development.

Authors:  Fanomezana M Ranaivoson; Qun Liu; Francesca Martini; Francesco Bergami; Sventja von Daake; Sheng Li; David Lee; Borries Demeler; Wayne A Hendrickson; Davide Comoletti
Journal:  Structure       Date:  2015-07-30       Impact factor: 5.006

Review 8.  The genetics of attention deficit/hyperactivity disorder in adults, a review.

Authors:  B Franke; S V Faraone; P Asherson; J Buitelaar; C H D Bau; J A Ramos-Quiroga; E Mick; E H Grevet; S Johansson; J Haavik; K-P Lesch; B Cormand; A Reif
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

Review 9.  Latrophilin-3 disruption: Effects on brain and behavior.

Authors:  Samantha L Regan; Michael T Williams; Charles V Vorhees
Journal:  Neurosci Biobehav Rev       Date:  2021-05-19       Impact factor: 9.052

Review 10.  Imaging genetics in adult attention-deficit/hyperactivity disorder (ADHD): a way towards pathophysiological understanding?

Authors:  Thomas Dresler; Beatrix Barth; Thomas Ethofer; Klaus-Peter Lesch; Ann-Christine Ehlis; Andreas J Fallgatter
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.